人类广泛中和抗体对各种E2表位的融合进化和向与HCV清除相关
Clinton O Ogega1, Nicole E Skinner2, Marta V Schoenle3
1Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Immunity
|March 22, 2024
概括
广泛中和抗体 (bNAbs) 是自发性型肝炎病毒 (HCV) 清除的关键. 这项研究发现了针对多个地点的多种bNAbs,提供了新的疫苗目标.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 疫苗开发 疫苗开发
背景情况:
- 自发性型肝炎病毒 (HCV) 清除与早期广泛中和抗体 (bNAbs) 有关.
- 大多数特征性bNAbs来自慢性感染的个体,并准E2糖蛋白的前层,通常利用VH1-69基因段.
研究的目的:
- 调查与自发HCV清除相关的bNAbs的遗传多样性和点.
- 在一个精英中和剂中描述B细胞受体 (BCR) 库,该中和剂清除了多个HCV感染.
主要方法:
- 一个精英的HCV中和剂的纵向BCR曲目分析.
- 隔离和表征E2反应性B细胞和单克隆抗体.
- 对抗体结合部位的BCR测序和分析.
主要成果:
- 从精英中和器中分离出的bNAbs显示出显著的遗传多样性,利用各种VH基因段.
- 这些bNAbs针对E2糖蛋白上至少有三个不同的抗原位点,包括以前非中和的位点.
- 发生了bNAb血统的融合进化,体质突变增强了中和幅度.
结论:
- 与HCV清除相关的bNAbs具有遗传多样性,并且针对E2包膜糖蛋白上的多个不同的抗原位点.
- 确定的bNAb目标代表了开发有效的HCV疫苗的有希望的候选人.
关键词:
B 细胞 B 细胞 B 细胞在BCR序列化中,BCR序列化在HCV病毒感染的过程中,抗体的进化是抗体的进化.广泛中和抗体的抗体.在C型肝炎病毒的感染中,一个单克隆抗体.中和化表位的表位.疫苗 疫苗 疫苗 疫苗更多相关视频
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
2.9K
12:09Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
Published on: February 28, 2019
9.8K
相关概念视频
Cross-reactivity
31.1K
Overview
31.1K
Retrovirus Life Cycles
45.9K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.9K
